CANCER RESEARCH TECHNOLOGY LIMITED
UK registered
Companies House number 01626049·27 UK shareholdings·2 ownership layers
CANCER RESEARCH TECHNOLOGY LIMITED is a UK-registered corporate shareholder (Companies House number 01626049) and holds shares in 27 active UK companies, recorded across 30 share-class positions on their Companies House confirmation statements (CS01). Beneath those direct holdings OpenRegistry resolves a further 1 companies spanning 2 ownership layers, of which 1 direct holdings are themselves holding companies; the persons-with-significant-control register independently agrees on 1 of these holdings. It ranks #225 of 54,210 corporate shareholders by number of active UK holdings. Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.
Identity
UK company 01626049
Jurisdiction
UNITED KINGDOM
Holdings that are holding companies
1
PSC register agrees on
1 holdings
Shareholdings
Every company CANCER RESEARCH TECHNOLOGY LIMITED appears on as a member, as filed. 27 of 27 are linked to their Companies House profile.
| Company held | Status | Accounts | Share class | Shares | % of class | % of capital | Total % of capital | As of |
|---|
| STRATOSVIR LIMITED13099988 | Active | TOTAL EXEMPTION FULL | ORDINARY | 16,984 | 12.73% | 12.73% | 12.73% | 2025-12-24 |
| ZYGOSITY LIMITED12760444 | Active | TOTAL EXEMPTION FULL | ORDINARY | 157,895 | 10.94% | 10.94% | 10.94% | 2023-07-21 |
| CELLINTA LTD12161294 | Active | MICRO ENTITY | ORDINARY | 714,286 | 8.48% | 8.48% | 8.48% | 2022-11-28 |
| NK:IO LTD12479455 | Active | TOTAL EXEMPTION FULL | SEED | 289,017 | 14.88% | 7.89% | 7.89% | 2024-03-20 |
| VERINNOGEN LIMITED13266666 | Active | TOTAL EXEMPTION FULL | ORDINARY A | 165,790 | 14.76% | 7.44% | 7.44% | 2026-03-14 |
| 52 NORTH HEALTH LTD11460425 | Active | TOTAL EXEMPTION FULL | SERIES SEED | 12,150 | 12.88% | 4.46% | 4.46% | 2026-02-21 |
| MOSAIC THERAPEUTICS LIMITED12780154 | Active | SMALL | SERIES A2 PREFERRED | 1,303,290 | 2.75% | 2.09% | 2.09% | 2025-07-29 |
| NUCLEARMEDIX LIMITED16134861 | Active | NO ACCOUNTS FILED | T ORDINARY SHARES | 1,090 | 21.80% | 1.09% | 1.09% | 2025-12-12 |
| BIOCAPTIVA LIMITEDSC609101 | Active | SMALL | ORDINARY £0.0001 | 14,750 | 0.81% | 0.81% | 0.81% | 2025-09-05 |
| GENOME THERAPEUTICS LTD12392992 | Active | SMALL | ORDINARY | 10,000 | 1.33% | 0.51% | 0.51% | 2026-01-07 |
| CYTED LTD11478299 | Active | GROUP | ORDINARY | 27,707 | 2.69% | 0.44% | 0.44% | 2025-07-22 |
| SIFTR BIO LIMITED15665818 | Active | MICRO ENTITY | T ORDINARY | 3,960 | 5.85% | 0.29% | 0.29% | 2025-04-21 |
| AKAMIS BIO LIMITED ▼06001442 | Active | GROUP | ORDINARY | 0 | 0.00% | 0.00% | | 2026-02-02 |
| MISSION THERAPEUTICS LIMITED07630933 | Active | FULL | ORDINARY | 283,500 | | | | 2025-05-11 |
| STORM THERAPEUTICS LIMITED09553473 | Active | GROUP | ORDINARY | 100,000 | | | | 2026-04-21 |
| ARTIOS PHARMA LIMITED09931309 | Active | GROUP | ORDINARY | 3,750,000 | | | | 2025-12-28 |
| GAMMADELTA THERAPEUTICS LTD10238425 | Active | FULL | ORDINARY SHARES | 0 | | | | 2023-06-16 |
| EPSILOGEN LTD10295520 | Active | FULL | ORDINARY | 600,000 | | | | 2025-07-25 |
| ELAITRA LTD11317171 | Active | MICRO ENTITY | A ORDINARY | 69,068 | | | | 2026-04-24 |
| MYRICX PHARMA LIMITED12082645 | Active | SMALL | T ORDINARY | 13,628 | | | | 2025-07-02 |
| SERIES A SHARES | 513,787 | | |
| SPLICEOR LTD12826144 | Active | TOTAL EXEMPTION FULL | ORDINARY. 0.000001 GBP | 25,106 | | | | 2025-08-19 |
| MANTRA DIAGNOSTICS LIMITED13040292 | Active | MICRO ENTITY | ORDINARY | 1,320 | | | | 2021-11-23 |
| NEOBE THERAPEUTICS LTD13146056 | Active | TOTAL EXEMPTION FULL | ORDINARY 0.001 GBP | 13,535 | | | | 2026-01-20 |
| A ORDINARY 0.001 GBP | 8,696 | | |
| ENEDRA THERAPEUTICS LIMITED13433538 | Active | TOTAL EXEMPTION FULL | ORDINARY | 16,842 | | | | 2025-06-01 |
| INFINITOPES LIMITED13642685 | Active | TOTAL EXEMPTION FULL | SEED | 121,951 | | | | 2024-09-23 |
| ORDINARY | 619,411 | | |
| TROGENIX LTD14930146 | Active | TOTAL EXEMPTION FULL | SEED | 3,500 | | | | 2024-06-11 |
| OLIGOTUNE LTD15373740 | Active | TOTAL EXEMPTION FULL | ORDINARY | 21,364 | | | | 2026-04-25 |
Ownership structure below these holdings
1 further companies sit beneath this entity’s direct holdings, across 2 layers. Each is linked to its Companies House profile.
Related company owners
Corporate shareholders that hold shares in the same UK companies as CANCER RESEARCH TECHNOLOGY LIMITED:
Other corporate shareholders of comparable size registered in UNITED KINGDOM:
Need the registered office, SIC code, accounts and filing history for CANCER RESEARCH TECHNOLOGY LIMITED? Open its Companies House profile at https://openregistry.sophymarine.com/insights/gb/01626049-cancer-research-technology-limited.